Remember meForgot password?
    Log in with Twitter

article imageSkin patch for migraines developed

By Tim Sandle     Jan 22, 2013 in Health
The company NuPathe have developed an innovative skin patch for migraines, which may be more effective than other types of medication.
Some good news for migraine suffers: a skin patch has been developed for the administering of anti-migraine medicine. The treatment has been given approval by the U.S. Food and Drug Administration (FDA).
The new medication has been called Zecuity. According to the information provided by NuPathe, Zecurity is a single-use, battery-powered patch that actively delivers the anti-migraine drug sumatriptan through the skin. Sumatriptan is the most widely prescribed migraine medication. Sumatriptan is produced and marketed by various drug manufacturers with many different trade names such as Sumatriptan, Imitrex, Treximet, Imigran, and Imigran recovery.
By incorporating sumatriptan the company is marketing the patch to provide relief for migraine headache pain and migraine-related nausea.
Armando Anido, NuPathe’s chief executive officer is quoted by Bloomberg as saying the following about the new medication: “We anticipate the product will be available for sale in the fourth quarter of this year. “We’re right now in conversations with a number of people for partnership in the United States.”
A migraine is a chronic neurological disorder characterized by recurrent moderate to severe headaches often in association with a number of autonomic nervous system symptoms.
The way of delivering drugs through patches (or what is scientifically termed an iontophoretic transdermal system) is becoming more popular, especially as an alternative to injections.
More about Migraine, Skin, skin patch, Headache
More news from
Latest News
Top News